
Venus Remedies Limited has informed the Exchange regarding a press release dated July 31, 2023, titled "Venus Remedies oncology wing product registrations go up to 506 with marketing approvals from four more countries.".
Filed with NSE ·

Venus Remedies Limited has informed the Exchange regarding a press release dated July 31, 2023, titled "Venus Remedies oncology wing product registrations go up to 506 with marketing approvals from four more countries.".
6ix hasn’t read this filing yet.
Follow Venus Remedies into a list and get an email when it puts out news.
Follow Venus Remedies